Inflammatory mediators associated with bone metabolism in patients awaiting lung transplantation

E. Kochetkova, L. Ugay, V. Nevzorova, G. Massard, T. Sourovenko (Vladivostok, Russian Federation; Strasbourg, France)

Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Session: Clinical management of lung diseases: from bronchi to pleura
Session type: Poster Discussion
Number: 399
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Kochetkova, L. Ugay, V. Nevzorova, G. Massard, T. Sourovenko (Vladivostok, Russian Federation; Strasbourg, France). Inflammatory mediators associated with bone metabolism in patients awaiting lung transplantation. Eur Respir J 2012; 40: Suppl. 56, 399

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Monitoring of lung function and airways inflammation after bone marrow transplantation
Source: Annual Congress 2008 - Risk factors for asthma versus asthma control
Year: 2008


Adipokines in end-stage lung diseases: The crosstalk between bone and adipose tissue
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013


Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Biochemical markers of bone remodeling in children with chronic lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 262s
Year: 2006

Late Breaking Abstract - Good outcome for lung transplantation for adults with interstitial lung disease associated with genetic disorders of surfactant metabolism
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Oxidized-polymers of Z-AT are associated with exaggerated pulmonary inflammation post lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012


Does perfusion with the organ care system influence inflammatory response in lung transplantation?
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016

Serum cytokines patterns in lung transplant recipients
Source: International Congress 2015 – Pathogenic mechanisms of lung transplant complications: a focus on CLAD
Year: 2015


Pulmonary infiltrates in hematopoietic stem cell trasplantation (HSCT) recipients. Associated pulmonary and systemic inflammatory response
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003

Mineralization and bone tissue metabolism in children with chronic inflammatory bronchopulmonary diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 318s
Year: 2003

The bone metabolism in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 256s
Year: 2002

Peripheral neutrophil stiffening in end-stage COPD patients undergoing lung transplantation
Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research
Year: 2008

Pulmonary involvement in haematological disorders and bone marrow transplant recipients
Source: Eur Respir Monogr 2019; 86: 333-358
Year: 2019


Fludarabine in paediatric steroid-refractory inflammatory lung injury after stem cell transplantation
Source: Eur Respir J 2013; 41: 479-483
Year: 2013


Lung transplantation after bone marrow transplantationin paediatric patients
Source: Eur Respir J 2006; 28: Suppl. 50, 725s
Year: 2006

Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury in lung transplantation
Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation
Year: 2004

Rapid decline in lung disease other than COPD: when should lung transplantation be considered?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007


Factors affecting lung function in adult cystic fibrosis patients after lung transplantation.
Source: International Congress 2018 – Evolving approaches to differential diagnosis
Year: 2018



Assessment of the restrictive allograft syndrome in patients after lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012